PP2 analog is widely used in biochemical research as a potent inhibitor of Src family kinases, which are crucial in cellular signaling pathways. It is particularly valuable in studies focused on understanding the role of these kinases in cancer progression, immune response, and cell differentiation. Researchers utilize PP2 analog to block kinase activity, allowing them to investigate the downstream effects on cellular processes and identify potential therapeutic targets. Additionally, it is employed in pharmacological studies to evaluate the efficacy of kinase inhibitors in preclinical models, aiding in the development of targeted cancer therapies. Its specificity and inhibitory properties make it a key tool in advancing knowledge of kinase-mediated signaling networks.